Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Lancet (London, England)|July 19, 2011
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialSube Banerjee, Jennifer Hellier, Michael Dewey, et al.International Psychogeriatrics|July 19, 2022
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trialCatherine Henderson, Martin Knapp, Susan Stirling, et al.Health Technology Assessment (Winchester, England)|November 6, 2023
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trialSube Banerjee, Nicolas Farina, Catherine Henderson, et al.International Journal of Geriatric Psychiatry|October 15, 2016
Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)Martin Knapp, Derek King, Renée Romeo, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2025
Lecanemab appropriate use recommendations for clinical practice in the UKCatherine J Mummery, Jill Rasmussen, Dan Blackburn, et al.The Lancet. Neurology|October 31, 2015
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Rupert McShane, James Lindesay, et al.International Journal of Geriatric Psychiatry|September 18, 2010
Determining the minimum clinically important differences for outcomes in the DOMINO trialRobert Howard, Patrick Phillips, Tony Johnson, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2020
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and managementJohn O'Brien, John Paul Taylor, Clive Ballard, et al.Age and Ageing|January 25, 2021
The effectiveness and cost-effectiveness of assistive technology and telecare for independent living in dementia: a randomised controlled trialRobert Howard, Rebecca Gathercole, Rosie Bradley, et al.Health Technology Assessment (Winchester, England)|March 23, 2021
Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCTRebecca Gathercole, Rosie Bradley, Emma Harper, et al.Pageof 17